NL7907916A - Nieuwe heterocyclische stikstofderivaten en werkwijzen voor de bereiding daarvan. - Google Patents
Nieuwe heterocyclische stikstofderivaten en werkwijzen voor de bereiding daarvan. Download PDFInfo
- Publication number
- NL7907916A NL7907916A NL7907916A NL7907916A NL7907916A NL 7907916 A NL7907916 A NL 7907916A NL 7907916 A NL7907916 A NL 7907916A NL 7907916 A NL7907916 A NL 7907916A NL 7907916 A NL7907916 A NL 7907916A
- Authority
- NL
- Netherlands
- Prior art keywords
- group
- formula
- compound
- hydrogen
- pyrano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7842679 | 1978-10-31 | ||
| GB7842679 | 1978-10-31 | ||
| GB7920760 | 1979-06-14 | ||
| GB7920760 | 1979-06-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7907916A true NL7907916A (nl) | 1980-05-02 |
Family
ID=26269406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7907916A NL7907916A (nl) | 1978-10-31 | 1979-10-29 | Nieuwe heterocyclische stikstofderivaten en werkwijzen voor de bereiding daarvan. |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US4419352A (cs) |
| AR (1) | AR230449A1 (cs) |
| AT (1) | AT379811B (cs) |
| AU (1) | AU528648B2 (cs) |
| BR (1) | BR7907006A (cs) |
| CA (1) | CA1142520A (cs) |
| CH (1) | CH643264A5 (cs) |
| CS (1) | CS231166B2 (cs) |
| CU (1) | CU21123A (cs) |
| DD (1) | DD146954A5 (cs) |
| DE (1) | DE2943658A1 (cs) |
| DK (1) | DK458679A (cs) |
| FI (2) | FI67702C (cs) |
| FR (1) | FR2440371A1 (cs) |
| GR (1) | GR73861B (cs) |
| HK (1) | HK66185A (cs) |
| HU (1) | HU183087B (cs) |
| IE (1) | IE49464B1 (cs) |
| IL (1) | IL58579A (cs) |
| KE (1) | KE3540A (cs) |
| LU (1) | LU81841A1 (cs) |
| MA (1) | MA18631A1 (cs) |
| MY (1) | MY8500439A (cs) |
| NL (1) | NL7907916A (cs) |
| NO (1) | NO154522C (cs) |
| NZ (1) | NZ191956A (cs) |
| PH (1) | PH15442A (cs) |
| PL (1) | PL130691B1 (cs) |
| PT (1) | PT70392A (cs) |
| SE (1) | SE451071B (cs) |
| SG (1) | SG40885G (cs) |
| SU (1) | SU1014476A3 (cs) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260306A (en) * | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
| GB8402047D0 (en) * | 1984-01-26 | 1984-02-29 | Fisons Plc | Nitrogen heterocycles |
| EP0162556B1 (en) * | 1984-04-13 | 1991-11-06 | FISONS plc | Novels forms and formulations of nedocromil sodium |
| GB8501015D0 (en) * | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
| GB8607159D0 (en) * | 1986-03-22 | 1986-04-30 | Smith & Nephew Ass | Pharmaceutical composition |
| HU202753B (en) * | 1986-06-21 | 1991-04-29 | Sandoz Ag | Process for producing retard pharmaceutical compositions containing cetotiphene |
| ES2058129T3 (es) * | 1986-12-23 | 1994-11-01 | Fisons Plc | Composiciones farmaceuticas que comprenden una solucion acuosa de un derivado de piranoquinolina. |
| USRE38628E1 (en) * | 1986-12-23 | 2004-10-19 | Fisons Plc | Pharmaceutical compositions |
| USH672H (en) | 1986-12-31 | 1989-09-05 | E. R. Squibb & Sons, Inc. | Stable antifungal capsule formulation |
| US4767612A (en) * | 1987-01-23 | 1988-08-30 | Rorer Pharmaceutical Corporation | Triamcinolone acetonide for the treatment of allergic rhinitis |
| GB8704089D0 (en) * | 1987-02-21 | 1987-03-25 | Fisons Plc | Method of treatment |
| GB2202145B (en) * | 1987-03-17 | 1991-01-02 | Fisons Plc | Compositions of nedocromil for dermatological use. |
| US5648084A (en) * | 1990-02-28 | 1997-07-15 | Guttag; Alvin | Multiple dosage medicine drop bottle |
| KR960014797B1 (ko) * | 1990-07-25 | 1996-10-19 | 이다가끼 히로시 | 벤조피란 유도체, 그의 제조법 및 그것을 함유하는 의약 조성물 |
| US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
| US5453431A (en) * | 1993-10-29 | 1995-09-26 | Gilman; Andrew L. | Use of hydroxychloroquine for treatment of graft-versus-host disease |
| ZA966579B (en) * | 1995-08-04 | 1998-02-02 | Wakamoto Pharma Co Ltd | O/W emulsion composition for eye drops. |
| US5891472A (en) * | 1996-11-19 | 1999-04-06 | Meri Charmyne Russell | Treatment of equine laminitis |
| US5989571A (en) * | 1997-07-23 | 1999-11-23 | Millenium Pharmaceutical Technologies, Inc. | Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory |
| US5885550A (en) * | 1998-07-02 | 1999-03-23 | Vallier; Deandra K. | Ophthalmic whitening solution |
| US7101547B1 (en) | 1999-01-22 | 2006-09-05 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies |
| US20050004377A1 (en) * | 2000-05-17 | 2005-01-06 | Robert Scarborough | Methods for producing amino substituted chromanes and intermediates therefor |
| US9132116B2 (en) | 2004-08-02 | 2015-09-15 | Willowcroft Pharm Inc. | Mast cell stabilizers to prevent or treat laminitis |
| GB0524808D0 (en) * | 2005-12-05 | 2006-01-11 | Novartis Ag | Organic compounds |
| DE102007028095A1 (de) * | 2007-06-19 | 2009-01-15 | Bachmann, Vincent | Zubereitung zur Behandlung von Hufrehe bei Equiden |
| FR2924344B1 (fr) * | 2007-12-04 | 2010-04-16 | Pf Medicament | Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4. |
| WO2010126544A1 (en) * | 2009-04-29 | 2010-11-04 | Willowcroft Pharm, Llc | Mast cell stabilizers to prevent or treat laminitis |
| CN116660407A (zh) * | 2023-05-18 | 2023-08-29 | 北京镁伽机器人科技有限公司 | 2,2-联喹啉-4,4-二甲酸二钠在腺病毒相关病毒滴度检测中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1504709A (en) * | 1974-12-07 | 1978-03-22 | Fisons Ltd | N-substituted quinolinone-2-carboxyl. acid der |
| AU513456B2 (en) * | 1977-03-08 | 1980-12-04 | Takeda Chemical Industries Ltd. | l-Azaxanthone-3-carboxylic acids |
| IL54614A (en) * | 1977-05-04 | 1983-07-31 | Fisons Ltd | Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them |
-
1979
- 1979-10-25 FR FR7926530A patent/FR2440371A1/fr active Granted
- 1979-10-26 GR GR60344A patent/GR73861B/el unknown
- 1979-10-26 CA CA000338555A patent/CA1142520A/en not_active Expired
- 1979-10-29 FI FI793369A patent/FI67702C/fi not_active IP Right Cessation
- 1979-10-29 NZ NZ191956A patent/NZ191956A/en unknown
- 1979-10-29 DE DE19792943658 patent/DE2943658A1/de active Granted
- 1979-10-29 CU CU7935159A patent/CU21123A/es unknown
- 1979-10-29 NO NO793469A patent/NO154522C/no unknown
- 1979-10-29 MA MA18832A patent/MA18631A1/fr unknown
- 1979-10-29 AU AU52287/79A patent/AU528648B2/en not_active Ceased
- 1979-10-29 PL PL1979219304A patent/PL130691B1/pl unknown
- 1979-10-29 CS CS797359A patent/CS231166B2/cs unknown
- 1979-10-29 IL IL58579A patent/IL58579A/xx unknown
- 1979-10-29 NL NL7907916A patent/NL7907916A/nl not_active Application Discontinuation
- 1979-10-29 BR BR7907006A patent/BR7907006A/pt unknown
- 1979-10-29 FI FI813127A patent/FI813127A7/fi not_active Application Discontinuation
- 1979-10-30 SU SU792838414A patent/SU1014476A3/ru active
- 1979-10-30 PH PH23228A patent/PH15442A/en unknown
- 1979-10-30 HU HU79FI718A patent/HU183087B/hu not_active IP Right Cessation
- 1979-10-30 PT PT70392A patent/PT70392A/pt not_active IP Right Cessation
- 1979-10-30 AR AR278695A patent/AR230449A1/es active
- 1979-10-30 CH CH971579A patent/CH643264A5/fr not_active IP Right Cessation
- 1979-10-30 LU LU81841A patent/LU81841A1/fr unknown
- 1979-10-30 DK DK458679A patent/DK458679A/da not_active Application Discontinuation
- 1979-10-30 SE SE7908995A patent/SE451071B/sv not_active IP Right Cessation
- 1979-10-30 DD DD79216552A patent/DD146954A5/de not_active IP Right Cessation
- 1979-10-30 AT AT0701479A patent/AT379811B/de not_active IP Right Cessation
- 1979-10-30 IE IE2074/79A patent/IE49464B1/en not_active IP Right Cessation
-
1981
- 1981-02-20 US US06/236,329 patent/US4419352A/en not_active Expired - Fee Related
-
1985
- 1985-05-29 KE KE3540A patent/KE3540A/xx unknown
- 1985-05-30 SG SG40885A patent/SG40885G/en unknown
- 1985-09-05 HK HK661/85A patent/HK66185A/xx unknown
- 1985-12-30 MY MY439/85A patent/MY8500439A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7907916A (nl) | Nieuwe heterocyclische stikstofderivaten en werkwijzen voor de bereiding daarvan. | |
| CN101268073B (zh) | 杂环化合物、制备方法及其用途 | |
| TW530048B (en) | New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation | |
| AU649453B2 (en) | Substituted benzimidazoles, process for their preparation and their pharmaceutical use | |
| WO2010039982A1 (en) | Crth2 modulators | |
| JPS6128673B2 (cs) | ||
| DE60215699T2 (de) | Quinolinone als prostaglandin rezeptor liganden | |
| HUT54991A (en) | Process for producing quinoline derivatives and pharmaceutical compositions comprising such compounds | |
| JPH0696581B2 (ja) | 新規なスルフエンアミド | |
| JPH07505407A (ja) | インドール誘導体 | |
| WO1993010783A2 (en) | Quinolone derivatives and their use as ampa and nmda receptor antagonists | |
| KR20020058091A (ko) | 신규한 1,8-나프티리딘-2(1ｈ)-온 유도체 | |
| KR900003650B1 (ko) | (1h-테트라졸-5-일)-2(1h)-퀴놀리논, 나프티리디논 및 그의 제조방법 | |
| JP2856548B2 (ja) | チオナフタレン誘導体およびその製法並びにそれを含む抗アレルギー剤 | |
| JPH09511483A (ja) | α−２−アドレノセプター作動剤として有用な６−（２−イミダゾリニルアミノ）キノリン化合物 | |
| DE69411375T2 (de) | FURO[3,2b]PYRIDINE UND THIENO[3,2b]PYRIDINE ALS INHIBITOREN DER LEUKOTRIENBIOSYNTHESE | |
| GB2035312A (en) | Oxygen containing heterocylics | |
| KR900003649B1 (ko) | (1H-테트라졸-5-일)테트라졸로[1,5-a]-퀴놀린의 제조방법 | |
| US4205073A (en) | Anti-diarrheal anilino nicotinic acids and method of using same | |
| JPS6231704B2 (cs) | ||
| WO2019232664A1 (zh) | 一类具有消炎免疫活性的磺酰基取代呋喃类化合物及其衍生物 | |
| KR20030086272A (ko) | 디히드로폴레이트 리덕타아제 저해제로서의디아미노퀴나졸린 에스테르 | |
| JPS58124783A (ja) | ３−（１ｈ−テトラゾ−ル−５−イル）−４（３ｈ）−キナゾリノン類 | |
| JPS63500518A (ja) | 多環式キノリン、ナフチリジンおよびピラジノピリジン誘導体 | |
| WO1999036068A1 (fr) | Activateurs des canaux de potassium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |